Alexandru Buzescu

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
  • G Tong, I Savant, +6 authors R Marcus
  • The Journal of Headache and Pain
  • 2013
Results BMS-927711 was well tolerated at single doses up to 1500 mg and at multiple doses up to 600 mg for 14 days. There were no serious adverse events (AEs). The maximum tolerated dose was not reached. The most common AEs among BMS-927711 groups during SAD were nausea (n=7 BMS; n=0 placebo, and dizziness (n=5 BMS; n=0 placebo), and were constipation (n=8(More)
  • 1